Latest proteomics Stories

Packing flaws create 'sticky,' interactive proteins that spread in small populationsOver four billion years of evolution, plants and animals grew far more complex than their single-celled ancestors. But a new comparison of proteins shared across species finds that complex organisms, including humans, have accumulated structural weaknesses that may have actually launched the long journey from microbe to man.The study, published in Nature, suggests that the random introduction of errors into...

SAN FRANCISCO, May 19, 2011 /PRNewswire/ -- Sutro Biopharma, a biopharmaceutical company developing novel and biosuperior protein therapeutics with improved pharmaceutical properties, today announced that a study published in the July issue of Biotechnology and Bioengineering demonstrates that the company's biochemical protein synthesis technology platform enables fast and high-yield protein synthesis and scale-up with straightforward downstream purification processes. In the study, the...

Cell signaling networks tied to diabetes and cancerResearchers at the University of Texas Medical Branch at Galveston and the University of California-San Diego School of Medicine have published a study that offers a new understanding of a protein critical to physiological processes involved in major diseases such as diabetes and cancer. This work could help scientists design drugs to battle these disorders.The article was deemed a "Paper of the Week" by and will be on the cover of...

AUSTIN, Texas, May 17, 2011 /PRNewswire/ -- Rules-Based Medicine (RBM), a global leader in biomarker testing services, today announced the acquisition of intellectual property assets from Satoris, Inc. The portfolio is based on extensive research to discover biomarkers and biomarker panels for clinical and research use in the areas of Alzheimer's disease, frontal temporal dementia, Parkinson's disease, and other conditions that affect the central nervous system. "These assets from...

MILFORD, Mass., May 11, 2011 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today welcomed into its Centers of Innovation Program the Proteomics Core Facility at the Duke University School of Medicine (Durham, NC). In a ceremony at Duke University, Waters recognized Associate Research Prof. M. Arthur Moseley, Director of Proteomics, for his research and support of ongoing research at the Duke University School of Medicine to bring about improvements in human health. Proteomics is a...

Mitochondria are the body's energy producers, the power stations inside our cells. Researchers at the University of Gothenburg, Sweden, have now identified a group of mitochondrial proteins, the absence of which allows other protein groups to stabilise the genome. This could delay the onset of age-related diseases and increase lifespan.Some theories of human ageing suggest that the power generators of the cell, the mitochondria, play a part in the process. In addition to supplying us with...

Virtual reality immerses students in proteins and peptidesHow do you get to know a protein? How about from the inside out?If you ask chemistry professor James Hinton, "It's really important that students be able to touch, feel, see ... embrace--if you like, these proteins."For decades, with funding from the National Science Foundation (NSF), Hinton has used nuclear magnetic resonance (NMR) to look at protein structure and function. But he wanted to find a way to educate and engage...

SANTA CLARA, Calif., May 9, 2011 /PRNewswire/ -- Cell Biosciences, Inc. today announced the issuance of three key patents by the United States Patent and Trademark Office, Patent Nos. 7,935,489, 7,935,308 and 7,935,479. These patents address central aspects of Cell Biosciences' NanoPro(TM) Assay Technology. NanoPro assay systems utilize novel approaches to protein capture and detection to enable high-sensitivity measurement of specific proteins in complex biological samples. These patents...

BERLIN and BURLINGTON, Mass., May 9, 2011 /PRNewswire/ -- caprotec bioanalytics GmbH, a privately held biopharmaceutical company offering the proprietary Capture Compound Mass Spectrometry (CCMS) platform technology for the analysis of small molecule - protein interactions, today announced a second closing of EUR 1 million ($1.4 M) to its Series B financing, increasing total equity for the round to EUR 5 million ($7.2 M). The capital increase was fully subscribed by LBBW Venture Capital...

Several genes have been linked to ALS, with one of the most recent called FUS. Two new studies in PLoS Biology, one from the University of Pennsylvania School of Medicine, and the other from colleagues at Brandeis University, both examined FUS biology in yeast and found that defects in RNA biology may be central to how FUS contributes to ALS, or Lou Gehrig's disease. These findings point to new targets for developing drugs.Proteins aggregate to form insoluble clumps in the brain and spinal...